Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...
Non-Invasive Prenatal Tests (NIPTs) are increasingly an integral part of screening during pregnancies across the world. Research from Amsterdam UMC shows that a pregnant woman's genetic background ...
In 2013 Susan Klugman, an obstetrician and geneticist who is currently president of the American College of Medical Genetics and Genomics, got back test results that were “really weird.” Her patient ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new policy for commercial coverage of its cfDNA Fetal RhD ...
When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...
BGI Genomics, with its partner Prom-Test Laboratories, celebrates the first localization of the Non-Invasive Prenatal Testing (NIPT) project in Armenia. The project launched in 2024 after a successful ...
After a prenatal test revealed that she had cancer, Dr. Sara Teichholtz (shown here with her 4-year-old son) was treated at MSK for cholangiocarcinoma. Nearly three years later, she has no evidence of ...
SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Sept. 2, 2024 /PRNewswire/ -- The global Non-invasive Prenatal Testing (NIPT) Market is valued at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback